AAAAAA
Results: 1-25/37
Authors:
FAVIER R
DESCHAMPS A
BELHOCINE R
ANKRI A
COSTIL J
DEMOERLOOSE P
Citation: R. Favier et al., SIMULTANEOUS ADMINISTRATION OF ANTITHROMBIN-III AND PROTEIN-C CONCENTRATES FOR THE TREATMENT OF A DEVASTATING COAGULOPATHY IN A CHILD, HEM CELL TH, 40(2), 1998, pp. 67-70
Authors:
SURVILLEBARLAND J
CAUMES E
ANKRI A
FRANCES C
KATLAMA C
CHOSIDOW O
Citation: J. Survillebarland et al., BLEOMYCIN-INDUCED DIGITAL GANGRENE, EJD. European journal of dermatology, 8(3), 1998, pp. 221-221
Authors:
KARMOCHKINE M
ANKRI A
CALVEZ V
BONMARCHANT M
COUTELLIER A
HERSON S
Citation: M. Karmochkine et al., PLASMA HYPERCOAGULABILITY IS CORRELATED TO PLASMA HIV LOAD, Thrombosis and haemostasis, 80(1), 1998, pp. 208-209
Authors:
CHADAREVIAN R
BRUCKERT E
ANKRI A
BEUCLER I
GIRAL P
TURPIN G
Citation: R. Chadarevian et al., RELATIONSHIP BETWEEN THYROID-HORMONES AND PLASMA D-DIMER LEVELS, Thrombosis and haemostasis, 79(1), 1998, pp. 99-103
Authors:
COMETS E
MENTRE F
POUSSET F
DIQUET B
MONTALESCOT G
ANKRI A
MALLET A
LECHAT P
Citation: E. Comets et al., MODELING INR DATA TO PREDICT MAINTENANCE FLUINDIONE DOSAGE, Therapeutic drug monitoring, 20(6), 1998, pp. 631-639
Authors:
MENTRE F
POUSSET F
COMETS E
PLAUD B
DIQUET B
MONTALESCOT G
ANKRI A
MALLET A
LECHAT P
Citation: F. Mentre et al., POPULATION PHARMACOKINETIC-PHARMACODYNAMIC ANALYSIS OF FLUINDIONE IN PATIENTS, Clinical pharmacology and therapeutics, 63(1), 1998, pp. 64-78
Authors:
MONTALESCOT G
PHILIPPE F
ANKRI A
VICAUT E
BEAREZ E
POULARD JE
CARRIE D
FLAMMANG D
DUTOIT A
CARAYON A
JARDEL C
CHEVROT M
BASTARD JP
BIGONZI F
THOMAS D
Citation: G. Montalescot et al., EARLY INCREASE OF VON-WILLEBRAND-FACTOR PREDICTS ADVERSE OUTCOME IN UNSTABLE CORONARY-ARTERY DISEASE - BENEFICIAL-EFFECTS OF ENOXAPARIN, Circulation, 98(4), 1998, pp. 294-299
Authors:
BASTARD JP
BRUCKERT E
GIRAL P
BEUCLER I
ANKRI A
HAINQUE B
TURPIN G
Citation: Jp. Bastard et al., PLASMINOGEN-ACTIVATOR INHIBITOR-1 ANTIGEN LEVELS ARE RELATED TO GAMMA-GLUTAMYL-TRANSFERASE IN HYPERLIPIDEMIC WOMEN, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 7(5), 1997, pp. 371-375
Authors:
MONTALESCOT G
ANKRI A
VEKEMANS B
BLACHER J
PHILIPPE F
DROBINSKI G
KAMOUN P
THOMAS D
Citation: G. Montalescot et al., HOMOCYSTEINE IS INCREASED IN PATIENTS WITH DIFFUSE ATHEROSCLEROSIS, Journal of the American College of Cardiology, 29(2), 1997, pp. 43136-43136
Authors:
KARMOCHKINE M
ANKRI A
MUGNIER P
BONMARCHAND M
HERSON S
Citation: M. Karmochkine et al., MARKERS OF ENDOTHELIAL INJURY AND MARKERS OF HEMOSTASIS ACTIVATION INHIV-INFECTION, Thrombosis and haemostasis, 1997, pp. 557-557
Authors:
ANKRI A
BONNEFONT JP
CHADEFAUXVEKEMANS B
MOSTEFA AK
AUPETIT J
COUTY MC
MONTALESCOT G
KAMOUN P
THUILLIER L
Citation: A. Ankri et al., THE 677C-T MUTATION IN THE METHYLENE-TETRAHYDROFOLATE REDUCTASE GENE IS NOT RELATED TO HYPERHOMOCYSTEINEMIA IN THROMBOTIC DISEASE, Thrombosis and haemostasis, 1997, pp. 2160-2160
Authors:
ANKRI A
MONTALESCOT G
CHADEFAUX B
COUTY MC
SOUNI F
THOMAS D
BINET JL
Citation: A. Ankri et al., PREVALENCE OF MILD HYPERHOMOCYSTEINEMIA IN ARTERIAL AND VENOUS THROMBOSIS DISEASE ACCORDING TO GENDER, Thrombosis and haemostasis, 1997, pp. 2167-2167
Authors:
ANKRI A
KARMOCHKINE M
COUTELLIER A
COUTY MC
HERSON S
Citation: A. Ankri et al., WHAT IS THE SIGNIFICANCE OF ANTIPHOSPHOLIPID ANTIBODIES (APL) IN HIV-INFECTED PATIENTS, Thrombosis and haemostasis, 1997, pp. 2207-2207
Authors:
ANKRI A
BRUHN HD
ENGELHARDT W
HAFNER G
KELLER F
PALARETI G
VANWERSCH JWJ
ZANDER N
Citation: A. Ankri et al., MULTICENTER EVALUATION OF A NEW RECOMBINANT THROMBOPLASTIN REAGENT, Thrombosis and haemostasis, 1997, pp. 2533-2533
Authors:
MONTALESCOT G
ANKRI A
CHADEFAUXVEKEMANS B
BLACHER J
PHILIPPE F
DROBINSKI G
BENZIDIA R
KAMOUN P
THOMAS D
Citation: G. Montalescot et al., PLASMA HOMOCYSTEINE AND THE EXTENT OF ATHEROSCLEROSIS IN PATIENTS WITH CORONARY-ARTERY DISEASE, International journal of cardiology, 60(3), 1997, pp. 295-300
Authors:
CHADAREVIAN R
BRUCKERT E
ANKRI A
BEUCLER I
GIRAL P
TURPIN G
Citation: R. Chadarevian et al., THYROID-HORMONES AS A DETERMINANT OF PLASMA D-DIMERS LEVELS IN HYPERLIPIDEMIC PATIENTS, Atherosclerosis, 134(1-2), 1997, pp. 188-188
Authors:
CHADAREVIAN R
BRUCKERT E
ANKRI A
DEJAGER S
COHENPRESBERG P
TURPIN G
Citation: R. Chadarevian et al., IS THERE A THRESHOLD LEVEL OF TRIGLYCERIDE ABOVE WHICH FACTOR VIIC AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 ARE ELEVATED, Atherosclerosis, 134(1-2), 1997, pp. 343-344
Authors:
MONTALESCOT G
PHILIPPE F
VICAUT E
BEAREZ E
POULARD JE
CARRIE D
FLAMMANG D
DUTOIT A
ANKRI A
BIGONZI F
Citation: G. Montalescot et al., AN EARLY INCREASE OF VON-WILLEBRAND-FACTOR PREDICTS ADVERSE OUTCOME IN UNSTABLE ANGINA - BENEFICIAL-EFFECTS OF ENOXAPARIN, Circulation, 96(8), 1997, pp. 3335-3335
Authors:
ANKRI A
MONTALESCOT G
CHADEFAUX B
BLACHER J
COUTY MC
KAMOUN P
THOMAS D
BINET JL
Citation: A. Ankri et al., MILD HYPERHOMOCYSTEINEMIA IS A GRADUATE RISK FACTOR FOR ARTERIAL AND VENOUS THROMBOSIS DISEASE, Blood, 90(10), 1997, pp. 667-667
Authors:
BASTARD JP
BRUCKERT E
PORQUET D
JARDEL C
ANKRI A
DELATTRE J
HAINQUE B
Citation: Jp. Bastard et al., EVIDENCE FOR A RELATIONSHIP BETWEEN PLASMINOGEN-ACTIVATOR INHIBITOR-1AND GAMMA-GLUTAMYL-TRANSFERASE, Thrombosis research, 81(2), 1996, pp. 271-275
Authors:
ANKRI A
CHADEFAUXVEKEMANS B
MOSTEFA AK
AUPETIT J
THUILLIER L
COUTY MC
MONTALESCOT G
KAMOUN P
BONNEFORT JP
Citation: A. Ankri et al., DOES THE PREVALENT MUTATION 677-]T IN THE METHYLENE-TETRAHYDROFOLATE REDUCTASE GENE CONTRIBUTE TO HYPERHOMOCYSTEINEMIA RELATED TO VASCULAR-DISEASE, Blood, 88(10), 1996, pp. 665-665
Authors:
BLACHER J
MONTALESCOT G
ANKRI A
CHADEFAUXVEKEMANS B
BENZIDIA R
GROSGOGEAT Y
KAMOUN P
THOMAS D
Citation: J. Blacher et al., HYPERHOMOCYSTEINAEMIA IN CORONARY-ARTERY DISEASE - RESULTS OF A STUDYOF 102 PATIENTS, Archives des maladies du coeur et des vaisseaux, 89(10), 1996, pp. 1241-1246
Authors:
BASTARD JP
BRUCKERT E
ROBERT JJ
ANKRI A
GRIMALDI A
JARDEL C
HAINQUE B
Citation: Jp. Bastard et al., ARE FREE FATTY-ACIDS RELATED TO PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN ANDROID OBESITY, International journal of obesity, 19(11), 1995, pp. 836-838
Authors:
MONTALESCOT G
ANKRI A
VICAUT E
DROBINSKI G
GROSGOGEAT Y
THOMAS D
Citation: G. Montalescot et al., FIBRINOGEN AFTER CORONARY ANGIOPLASTY AS A RISK FACTOR FOR RESTENOSIS, Circulation, 92(1), 1995, pp. 31-38
Authors:
TOULON P
ANKRI A
TOURNERIE C
SERENI D
Citation: P. Toulon et al., EFFECT OF GEM-91, A PHOSPHOROTHIOATE OLIGONUCLEOTIDE ON THE COAGULATION SYSTEM RESULTS OF EX-VIVO AND IN-VITRO STUDIES, Blood, 86(10), 1995, pp. 3544-3544